Todd E. Golde, M.D., Ph.D., an internationally-known expert in the scientific understanding of Alzheimer’s disease, has been appointed executive director of the Evelyn F. and William L. McKnight Brain Institute of the University of Florida. His appointment will be effective as of December 1.
Golde, currently a professor of neuroscience and director of UF’s Center for Translational Research in Neurodegenerative Disease and the 1Florida Alzheimer’s Disease Research Center consortium of institutions, has served the MBI for six years as both an investigator and a leader, pioneering programs to closely link basic-science laboratory work with patient-based studies to translate new discoveries into diagnoses and treatments.
Golde was selected as the new MBI director after an extensive national search. Interim executive director Steven T. DeKosky, M.D., will continue as deputy director.
Golde came to UF Health from the Mayo Clinic in Jacksonville, bringing a wealth of administrative and strategic-planning experience. As chair of Mayo’s department of neuroscience, he oversaw an extramural grant portfolio that exceeded $10 million a year.
An investigator into the study of Alzheimer’s disease for almost three decades, Golde has published more than 220 papers that have been cited more than 25,000 times. He has expanded his leading-edge research to include other neurodegenerative diseases, cancer and even malaria.
